Table 3.
95% CI |
||||
---|---|---|---|---|
Factor | Odds ratio | Low | High | P-value |
Predisposing | ||||
Age | ||||
Male | 1.03 | 0.47 | 2.27 | 0.943 |
White | 1.94 | 0.97 | 3.88 | 0.062 |
Hispanic | ||||
Married/living w partner | ||||
High school education or more | 0.97 | 0.50 | 1.87 | 0.924 |
Enabling/inhibiting resources | ||||
Income over $20,000 per year | ||||
Homeless | 0.29 | 0.14 | 0.62 | 0.001 |
Working full or part-time | ||||
Ever talked to professional about alcohol | 2.57 | 1.28 | 5.16 | 0.008 |
Received treatment for alcohol in past 12 months | ||||
PHQ8 scale for depression | 1.04 | 0.98 | 1.09 | 0.219 |
Need | ||||
Co-occurring diagnosis of opioid use disorder | ||||
ER visit or overnight hospital stay in past 90 days | ||||
Negative consequences from substance use | 1.06 | 0.99 | 1.14 | 0.093 |
Received XR-NTX | 4.34 | 1.79 | 10.54 | 0.001 |
Note: XR-NTX = Injectable Extended-Release Naltrexone; PHQ8 = eight-item Patient Health Questionnaire depression scale; ER = emergency room; CI = confidence interval.
A11 models included site and clinical trial enrollment group.